Skip to main content
BMJ Medicine logoLink to BMJ Medicine
. 2026 Jul 6;5(1):e001558. doi: 10.1136/bmjmed-2025-001558

Gestational weight gain and maternal immediate perinatal and postpartum outcomes in low and middle income countries: individual participant data meta-analyses

Uttara Partap 1,2,✉, Janaína Calu Costa 1,3, Enju Liu 4,5, Ilana R Cliffer 1,6, Dongqing Wang 7, Molin Wang 8,9,10, Sudeer Kumar Nookala 11, Vishak Subramoney 12, Brittany Briggs 13, Ajibola Ibraheem Abioye 1, Manfred Accrombessi 14, Seth Adu-Afarwuah 15, Sheraz Ahmed 16, Hellen Akurut 17, Hasmot Ali 18,19, Asad Ali 16, Joao Guilherme Alves 20, Teddy Andra 21, Carla Adriane Leal de Araújo 20, Alemayehu Argaw 22, Shams Arifeen 23, Rinaldo Artes 24, Per Ashorn 25, Ulla Ashorn 25, Fereidoun Azizi 26, Bowen Banda 27, Ahmed Tijani Bawah 28, Nita Bhandari 29, Zulfiqar A Bhutta 30,31, Valerie Briand 32, Elvira Beatriz Calvo 33, Marly Augusto Cardoso 34, Marcia Caldas de Castro 35, Jose Guilherme Cecatti 36, Gabriela Chico-Barba 37, Ranadip Chowdhury 29, Parul Christian 38, Shalean Collins 39, Anthony Costello 40, Kathryn G Dewey 41, Titus H Divala 42, Jamille Gregório Dombrowski 43, Michele Drehmer 44, Christopher P Duggan 1,45,46, Pratibha Dwarkanath 47, Alison M Elliott 17,48, Davaasambuu Enkhmaa 49, Daniel Erchick 19, Guadalupe Estrada-Gutierrez 50, Frankie J Fair 51, Henrik Friis 52, Jimena Fritz 53, Samira Behboudi Gandevani 54, Davaasumbuu Ganmaa 35,55,56, Armando García-Guerra 57, Alison D Gernand 58, Exnevia Gomo 59, Austrida Gondwe 60, Isabel González-Ludlow 61, Rebecca Grais 62, Ousmane Guindo 63, Lotta Hallamaa 25, Davidson H Hamer 64,65,66, Giles Hanley-Cook 22, Alain Hien 67, Lieven Huybregts 22,68, Sheila Isanaka 62, Fyezah Jehan 69, Gilberto Kac 70, Richard Kajubi 21, Abel Kakuru 21, Margaret P Kasaro 71, Joanne Katz 19, Subarna K Khatry 72, Nancy F Krebs 73, Pratap Kumar 74, Anura V Kurpad 75, Carl Lachat 22, Tsering Pema Lama 72, Hector Lamadrid-Figueroa 76, Hermann Lanou 77, Anna Lartey 15, Miriam K Laufer 78, See Ling Loy 79,80, Nur Indrawaty Lipoeto 81, Laura Beatriz López 82, Liania Alves Luzia 83, Abdullah Mahmud 84,85, G Arun Maiya 86, Kenneth Maleta 87, Dharma S Manandhar 88, Mark J Manary 89, Charles Mangani 87, Claudio Romero Farias Marinho 43, Hugo Martínez-Rojano 90, Susana L Matias 91, Alicia Matijasevich 92, Elizabeth M McClure 93, Sotero S Mengue 94, Joshua D Miller 95, Sophie E Moore 96,97, Marhazlina Mohamad 98, Hamid Jan Jan Mohamed 99, Malay Kanti Mridha 100, Ferdinand M Mugusi 101, Ameer Muhammad 102, Alfa Muhihi 103, T Verenice Muñoz-Rocha 53, Wilbroad Mutale 104, Lynnette M Neufeld 105, Phuong Hong Nguyen 106, Maria Angélica Antunes Nunes 107, Maria Ome-Kaius 108, David Osrin 40, Noel Patson 109, Andrea B Pembe 110, Otilia Perichart-Perera 111, Karen E Peterson 112, Zul Premji 113, Andrew M Prentice 97, Amado D Quezada-Sánchez 114, Najeeb Rahman 16, Preetha Ramachandra 115, Usha Ramakrishnan 116, Arjumand Rizvi 31, Dominique Roberfroid 117,118, Patricia Lima Rodrigues 119, Stephen J Rogerson 120, Patricia HC Rondó 83, Daniel E Roth 121, Reyna Sámano 111, Naomi M Saville 122, Maria Inês Schmidt 94, Katherine EA Semrau 56,123, Yasir Shafiq 35,124,125, Saijuddin Shaikh 18,19, Bhim P Shrestha 126, José Roberto Da Silva Jr 127, Hora Soltani 51, Sajid Soofi 128, Rodrigo Medeiros Martorano 129, Renato Teixeira Souza 36, Dan J Stein 130, Jeffrey SA Stringer 131, Christopher R Sudfeld 1,8,46, Sunita Taneja 29, Fahimeh Ramezani Tehrani 132, Tinku Thomas 133, James M Tielsch 134, Laéticia Céline Toe 22,135, Holger W Unger 136, Willy Urassa 137, Juliana dos Santos Vaz 138, Audêncio Victor 83, Emily L Webb 48, Keith P West Jr 19, Elizabeth Widen 139, Lesley Workman 140, Robert O Wright 141, Lee Shu Fune Wu 19, Sera L Young 142, Heather Zar 140, Lingxia Zeng 143, Wafaie W Fawzi 1,8,46
PMCID: PMC13358349  PMID: 42445525

Abstract

Objective

To estimate the associations between gestational weight gain and maternal immediate perinatal and postpartum outcomes by pooling data from low and middle income countries.

Design

Individual participant data meta-analyses.

Data sources

PubMed, Embase, Web of Science, and Cochrane Library, based on three searches (Search 1: all prospective studies published from January 2000 to May 2021; Search 2: randomized controlled trials of balanced energy and protein supplementation published until June 2021; Search 3: randomized controlled trials of anti-infectious agents published until August 2021).

Eligibility criteria for selecting studies

Prospective studies (randomised controlled trials or observational cohort studies) with measured maternal weight during pregnancy and data available on maternal height, based in populations from low and middle income countries with no underlying conditions.

Results

The analyses included 156 300 women from 61 studies and 23 countries, with most participants based in South Asia (n=78 454, 50.2%) and sub-Saharan Africa (n=36 327, 23.2%). Compared with women with adequate (90-125%) gestational weight gain, women with excessive (>125%) gestational weight gain had a higher risk of caesarean delivery (risk ratio 1.10, 95% confidence interval 1.06 to 1.13, τ2=0.000) and emergency caesarean delivery (risk ratio 1.22, 1.03 to 1.43, τ2=0.000). Women with moderately (70% to <90%) or severely inadequate (<70%) versus adequate gestational weight gain had lower risks for caesarean delivery (risk ratio in women with moderately inadequate gestational weight gain 0.88, 95% confidence interval 0.84 to 0.92, τ2=0.004; risk ratio in women with severely inadequate gestational weight gain 0.82, 0.77 to 0.88, τ2=0.010) and emergency caesarean delivery (risk ratio in moderately inadequate gestational weight gain 0.82, 0.71 to 0.95, τ2=0.004; risk ratio in severely inadequate gestational weight gain 0.73, 0.56 to 0.96, τ2=0.103). Excessive versus adequate gestational weight gain was associated with higher postpartum weight retained at any time point (mean difference 2.00 kg, 95% confidence interval 1.49 to 2.50, τ2=1.317), whereas moderately and severely inadequate gestational weight gain were associated with lower retained weight compared with adequate gestational weight gain. Similar trends were found for postpartum body mass index. Severely inadequate gestational weight gain was associated with lower systolic and diastolic blood pressure at any time point post partum than adequate gestational weight gain. No associations were observed for other outcomes including postpartum depressive symptoms or breastfeeding. Evidence indicating an interaction between gestational weight gain and body mass index before pregnancy was found when examining the risk of caesarean delivery and postpartum weight retention, body mass index, and systolic blood pressure as outcomes.

Conclusions

These findings support the association between suboptimal gestational weight gain and adverse maternal outcomes in the immediate perinatal and postpartum periods. Further research examining the consequences of suboptimal gestational weight gain in low and middle income countries would be valuable to inform potential strategies to improve long term maternal health.

Review registration

PROSPERO CRD42023432836

Keywords: Nutritional sciences, Obstetrics, Public health, Epidemiology


WHAT IS ALREADY KNOWN ON THIS TOPIC

  • Robust, large scale analyses based in low and middle income countries have shown associations between inadequate or excessive versus adequate gestational weight gain and adverse neonatal outcomes, including low birth weight, small for gestational age, microcephaly, preterm birth, and macrosomia

  • Most available data on potential maternal consequences of suboptimal gestational weight gain are from high income countries

  • Robust evidence for associations between inadequate or excessive gestational weight gain and maternal perinatal and postpartum outcomes from low and middle income countries is limited

WHAT THIS STUDY ADDS

  • An increased risk of caesarean and emergency caesarean delivery, and higher postpartum weight retention and body mass index, was associated with excessive versus adequate gestational weight gain

  • Clear or consistent associations between gestational weight gain and other immediate perinatal complications, postpartum depression, waist circumference, blood pressure, or breastfeeding difficulty were not found

HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE, OR POLICY

  • These results indicate important potential maternal health consequences associated with suboptimal gestational weight gain in low and middle income countries

  • More robust evidence is needed to confirm these findings and the potential value of interventions that focus on optimising gestational weight gain for improved maternal health in these settings

Introduction

Gestational weight gain is increasingly recognised as a key potential determinant of pregnancy outcomes. Substantial evidence has indicated associations between suboptimally low or high gestational weight gain and the risk of adverse neonatal outcomes.1–3 Specifically, recent large scale analyses based on data pooled from studies in Latin America, Asia, and Africa indicated that severely inadequate gestational weight gain was associated with increased risks of adverse outcomes of up to 40-60%, including low birth weight, small for gestational age, short for gestational age, and microcephaly, with increased risks also observed for moderately inadequate gestational weight gain.1 Excessive gestational weight gain was also associated with an increased risk of preterm birth, large for gestational age, and macrosomia.1 Because of its modifiable nature, this available evidence indicates that gestational weight gain may be a useful target for strategies aiming to reduce the risk of these outcomes.

Emerging literature also indicates the potential influence of suboptimal gestational weight gain on adverse maternal outcomes at the time of delivery and in the longer term. These adverse outcomes include immediate perinatal outcomes (at the time of delivery), such as caesarean delivery,4 5 postpartum measures, such as breastfeeding success,6 and longer term outcomes, including postpartum depression,7 postpartum weight retention,8 and development of cardiometabolic disease.8–10 Many of these outcomes are interrelated and have multifactorial determinants and complex development pathways.11 12 Recent studies have focused particularly on the relation between excessive gestational weight gain and these outcomes, with effects on immediate perinatal outcomes thought to be mediated by mechanisms relating to the mismatch between fetal and pelvic size.13 Effects on other outcomes, including breastfeeding success, are considered to be at least partly a result of endocrine and inflammatory mechanisms related to adiposity.6 14 Evidence of the potential maternal consequences of inadequate gestational weight gain is limited, with research suggesting negative associations with measures such as starting breastfeeding.6

Much of the available evidence on suboptimal gestational weight gain and adverse maternal outcomes comes from studies conducted in higher income countries, with limited data from low and middle income countries,15–17 despite a notable burden of both inadequate and excessive gestational weight gain in these countries.3 18 19 Evidence from low and middle income countries about the role of suboptimally low or high gestational weight gain in the development of poor maternal outcomes may help to inform strategies aiming to maintain healthy gestational weight gain, reduce the risk of these outcomes, and promote longer term maternal and child health in these settings. Therefore, collating and considering the available evidence on associations between gestational weight gain and maternal outcomes in a robust manner is needed, particularly for low and middle income countries.

We conducted individual participant data meta-analyses to estimate the association between gestational weight gain and maternal outcomes at delivery and post partum. The individual participant data meta-analyses were based on data pooled from studies measuring maternal pregnancy weight across low and middle income countries in Asia, Africa, and Latin America. We also explored the potential modification of associations with gestational weight gain by body mass index before pregnancy. We considered outcomes such as immediate perinatal complications, psychosocial health, anthropometric and cardiometabolic status, and indicators related to breastfeeding. Considering that a gestational weight gain reference does not currently exist that is representative of populations from low and middle income countries across the range of categories of body mass index before pregnancy, we focused on the adequacy of gestational weight gain defined by the 2009 recommendations of the US Institute of Medicine.20

Materials and methods

Objectives

The primary objective of this set of individual participant data meta-analyses was to quantify associations between suboptimal gestational weight gain (severely inadequate gestational weight gain, moderately inadequate gestational weight gain, and excessive gestational weight gain v adequate gestational weight gain) and maternal immediate perinatal (at the time of delivery) and postpartum outcomes in women living in low and middle income countries. Specifically, we assessed the risk of caesarean delivery, emergency caesarean delivery, perineal tears, postpartum haemorrhage, obstructed or prolonged labour, postpartum depressive symptoms, and any or exclusive breastfeeding at any time post partum. We also recorded mean difference in weight retention, body mass index, waist circumference, and systolic and diastolic blood pressure measured at any time post partum in women with suboptimal versus adequate gestational weight gain. The secondary objective of the analysis was to examine whether associations between gestational weight gain and maternal outcomes might be modified by body mass index before pregnancy (underweight, normal, and overweight or obese).

Literature search and data acquisition

This set of individual participant data meta-analyses was conducted as part of the Gestational Weight Gain Pooling Project, a data pooling project to understand the distribution, determinants, and consequences of suboptimal gestational weight gain in low and middle income countries. This data pooling project was conducted in two phases (phases 1 and 2). Phase 1 (2019-21) of the Gestational Weight Gain Pooling Project comprised an investigation of gestational weight gain distribution,18 sociodemographic and clinical predictors,19 nutritional interventions,21 and associated neonatal outcomes.1 Phase 2 (2021-24) extended this work under a separate funding grant, including updating analyses of gestational weight gain distribution,22 and examining additional dietary and psychosocial predictors, nutritional and clinical interventions,23 24 and maternal outcomes. Our study was a research aim under phase 2 of the pooling project.

In phase 1 of the Gestational Weight Gain Pooling Project, we conducted systematic literature searches in PubMed, Embase, and Web of Science in February and March 2019, with the final searches conducted by 31 March 2019, restricted to publications on or after 1 January 2000. Eligible studies were prospective studies (randomised controlled trials or observational cohort studies) with measured maternal weight during pregnancy and data available on maternal height, based in populations from low and middle income countries with no underlying conditions (eg, HIV). Retrospective studies analysing maternal weight data from routine medical records were not eligible. The results of the original searches and initial analytical outputs are described in detail elsewhere.1 19 21 The main research aims of phase 1 did not include examining maternal outcomes and therefore all of the available relevant data for our analyses were not originally collated from participating investigators. In 2021, we re-contacted all investigators to confirm interest in participating in phase 2, and to request any additional relevant data available to share. Because of funding constraints, we considered all studies in phase 1 of the Gestational Weight Gain Pooling Project where any relevant data could be harmonised (ie, where the required variables were identified and made into consistent format for use across all datasets) before 4 March 2024. In total, we identified and included relevant variables from 46 phase 1 studies (figure 1).

Figure 1.

Figure 1

Flowchart of study inclusion for analysis. *The full flowchart for phase 1 has been published previously.1 SS= systematic search.

In phase 2 of the Gestational Weight Gain Pooling Project on 20 May 2021, we updated the systematic searches that were conducted in phase 1, based on the same databases as well as the Cochrane Library and with the same eligibility criteria. We also performed two additional systematic searches with related aims. In the first search, performed on 2 June 2021, we identified all randomised controlled trials published so far that examined balanced energy and protein supplementation versus any treatment not involving balanced energy and protein supplementation during pregnancy in low and middle income countries.23 In the second search, performed on 4 August 2021, we identified all randomised controlled trials published so far examining antenatal anti-infectious agents in low and middle income countries.24 These searches were supplemented with manual searches of relevant systematic reviews and information provided by colleagues on ongoing studies. We contacted all investigators and produced data sharing arrangements for those interested and who had relevant data available. Because of funding constraints, we considered all studies where data sharing agreements could be established, data were shared, and relevant data could be harmonised before 4 March 2024. In total, we included data from 15 phase 2 studies in this analysis (figure 1 and online supplemental table 1).

Supplementary data

bmjmed-5-1-s001.pdf (9.6MB, pdf)

Variables of interest and inclusion of participants

For our analyses, we included women with singleton pregnancies with data for gestational age at each weight measurement and for date of delivery. Data for sex were taken from the included studies rather than from patient reported gender. Participants were pregnant women and other pregnant people. To ensure calculation of the gestational weight gain metric of interest, participants were included who had at least one weight measurement before pregnancy or in early pregnancy (first trimester) and one measurement after the first trimester, or at least one weight measurement in the second trimester. For women with one weight measurement in the second trimester, early pregnancy weight was imputed with validated methods based on mixed effects restricted cubic spline models previously described elsewhere,25 grouped by geographic region. This method assumes that missingness is at random, that the subject specific random intercepts and slopes follow a normal distribution, and that the error follows a mean zero normal distribution.25 Compared with other simple (eg, arithmetic imputation based on nearest measures) and more complex (eg, marginal models with generalised estimating equations) imputation methods, this method was found to most accurately predict early pregnancy weight in two longitudinal pregnancy cohorts in Tanzania (mean absolute error between observed and imputed values, 1.99 kg and 1.60 kg).25

Calculation of gestational weight gain

The predictor of interest was total gestational weight gain adequacy ratio, defined according to the criteria of the Institute of Medicine. Briefly, gestational weight gain adequacy was calculated as gestational weight gain observed between weight before pregnancy or in the first trimester and the latest time point in pregnancy as a percentage of gestational weight gain recommended or expected during the same time period, according to the recommendations of the Institute of Medicine.20 Box 1 outlines the calculations.26

Box 1. Calculation of gestational weight gain.
  • Observed gestational weight gain=Last available weight – observed weight before pregnancy or observed or imputed first trimester weight

  • Recommended gestational weight gain by Institute of Medicine 2009=((Expected first trimester total weight gain by body mass index category/13+6 weeks*) × (13+6 weeks* − gestational age at first measured or imputed weight measure)) + ((gestational age at the last weight measurement – 13+6 weeks*) × Institute of Medicine recommended rate of gestational weight gain for the second and third trimesters by body mass index category)20

  • Total gestational weight gain adequacy ratio=(Observed gestational weight gain/recommended gestational weight gain) × 100%

*Gestational age 13+6 weeks=13 weeks and 6 days.

For calculations and use in analyses, body mass index category was based on the observed weight before pregnancy or observed or imputed first trimester weight. For women aged ≥20 years, body mass index was categorised as underweight (<18.5), normal (18.5-24.9), overweight (25-29.9), or obese (≥30).27 For those aged <20 years, body mass index was categorised based on the World Health Organization 2007 reference as underweight (<−2 standard deviations, SD), normal (−2 to <1 SD), overweight (1 to <2 SD), or obese (≥2 SD).28

The total gestational weight gain adequacy ratio was categorised as severely inadequate (<70%), moderately inadequate (70% to <90%), adequate (90-125%), or excessive (>125%), as done previously, with adequate gestational weight gain being the referent category.1 19 The cut-off values of >125% and <90% reflect the upper and lower limits of recommended gestational weight gain by the Institute of Medicine, and the cut-off value of <70% (severely inadequate) was added to reflect the severity of inadequate gestational weight gain in low and middle income countries, because the recommendations of the Institute of Medicine are based on high income populations.1 19 To ensure biological plausibility, we excluded from our analyses participants with a total gestational weight gain adequacy ratio at extremes (study specific ≤1st centile and ≥99th centile).

Because the recommendations of the Institute of Medicine are based on data from high income populations, as part of our secondary analyses, we also examined gestational weight gain adequacy expressed with INTERGROWTH-21st (International Fetal and Newborn Growth Consortium for the 21st Century) standards for gestational weight gain,29 where recommended gestational weight gain (denominator) was set as the gestational age specific mean gestational weight gain based on the standard curves. The INTERGROWTH-21st standards for gestational weight gain were constructed only for participants with a normal body mass index before pregnancy, and therefore we restricted our analyses to this subpopulation (with body mass index calculated based on observed weight before pregnancy, or observed or imputed first trimester weight).

Outcomes of interest

Outcomes of interest that we originally considered included immediate perinatal complications (ie, complications at the time of delivery, covering caesarean delivery (scheduled and emergency), perineal tears, cephalopelvic disproportion, shoulder dystocia, obstructed and prolonged labour, perinatal asphyxia, postpartum haemorrhage, postpartum infection or sepsis, maternal death, and length of stay at health facility), psychosocial health (postpartum depression, anxiety, or stress), nutritional (including anthropometric measurements such as postpartum weight, body mass index, waist circumference, iron deficiency, and anaemia), cardiometabolic measures (blood pressure, dyslipidaemia, dysglycaemia, diabetes, and metabolic syndrome), inflammatory measures (levels of C reactive protein, alpha(1) acid glycoprotein, and interleukin 6), and indicators related to breastfeeding (starting breastfeeding, length of breastfeeding, and any or exclusive breastfeeding at any time point). Outcomes in these domains have previously been linked with gestational weight gain and often also with body mass index before pregnancy, with some hypotheses on plausible mechanisms of effect.4–10 13 14 Studies with extensive missingness on outcome values (defined as n<50 observations and <10% of total sample available) were not considered for pooling (online supplemental tables 2 and 3).

Our aim was to pool data where three or more studies were available for each outcome and therefore outcomes included in the final analyses were: caesarean delivery (either emergency or scheduled, v vaginal delivery; n=56 studies), emergency caesarean delivery (v vaginal delivery; n=16 studies), perineal tears (observed or abstracted from records by the study team or self-reported by participants; n=8 studies), postpartum haemorrhage (excessive bleeding after birth, as observed or abstracted by the study team or self-reported by participants; n=11 studies), obstructed or prolonged labour (observed or abstracted by the study team or self-reported by participants or, where possible, defined as labour lasting >20-24 hours; n=9 studies), postpartum depressive symptoms (being in the study specific top 20% group v lower 80% group for depressive symptom scores, to account for the varying scales used across studies; n=7 studies), postpartum weight retention (defined as the difference between weight at any time point post partum and weight before pregnancy or in the first trimester; n=32 studies), body mass index (n=32 studies) and waist circumference (n=3 studies) measured at any time point post partum, systolic and diastolic blood pressure measured at any time point post partum (n=17 studies), and currently any breastfeeding and exclusively breastfeeding (as binary variables; n=14 and n=10 studies, respectively) at any time point post partum (online supplemental tables 2 and 3). We conducted risk of bias assessments for the included studies with the QUIPS (Quality in Prognosis Studies) risk of bias assessment instrument for prognostic factor studies (online supplemental table 5).30

Covariates

Based on previous research4–10 13 14 and data availability, we developed directed acyclic graphs to guide the selection of potential confounders (figure 2). These potential confounders were adjusted for where possible in all analyses: maternal age, parity, maternal education and wealth, body mass index before pregnancy (based on observed weight before pregnancy, or observed or imputed first trimester weight), intervention arm (for randomised controlled trials), and study cluster (for clustered studies, this variable was included in models as a random effect). For analyses examining immediate perinatal and breastfeeding outcomes, we also adjusted for diabetes or hypertension before pregnancy, alcohol or smoking in pregnancy, malaria in pregnancy, and HIV status, where possible. Analyses examining nutritional and cardiometabolic measures were further adjusted for ever consuming alcohol or smoking, HIV status, and any physical activity at any available time point. Analyses examining postpartum weight retention and body mass index were also adjusted for breastfeeding status at that time point.

Figure 2.

Figure 2

Directed acyclic graphs guiding analytical models. *Sociodemographic (and design related) confounders: maternal age, parity, maternal education and wealth, intervention arm (for trials), and study cluster (random effect)

For analyses examining systolic and diastolic blood pressure, we excluded participants with known pre-existing hypertension. Models assessing depressive symptoms were further adjusted for ever consuming alcohol or smoking, HIV status, any physical activity in pregnancy, and diabetes or hypertension recorded at any time. Models with measures at multiple time points included number of days post partum as a covariate and were adjusted for clustering by participant identifier. Missing data on covariates, in studies where these were measured, were handled with the missing indicator method.31

Statistical analyses

The primary analysis was a two stage individual participant data meta-analysis because this approach offers greater flexibility in terms of modelling, handling of available confounders, assessing heterogeneity across studies, and dealing with bias in interaction models.32 For each meta-analysis, participants with available data on the outcomes of interest were considered for inclusion. Study specific estimates were generated. For single time point measures, Poisson or linear regression models with robust standard errors (or corresponding mixed effects regressions for studies with cluster variables) were constructed. For multiple time point measures, mixed effects Poisson or linear regression models adjusted for clustering at the individual level (and any other study specific clusters) with robust standard errors were constructed. Gestational weight gain was modelled as a categorical predictor (severely inadequate, moderately inadequate, or excessive v adequate). Models for each outcome were adjusted for all available relevant confounders, as described above. Study specific estimates were then combined by using random effects meta-analyses (restricted maximum likelihood (REML) method, with Hartung-Knapp adjustment for derivation of 95% confidence intervals). As part of these analyses, we also examined 95% prediction intervals to estimate potential effects in a new study.

Studies with implausible risk ratio point estimates of >10 or <0.01, generally because of low or zero occurrence of the outcome in certain groups, were not included in the meta-analyses (maximum studies excluded in one meta-analysis: n=7 for caesarean delivery, n=2 for emergency caesarean delivery, n=1 for postpartum haemorrhage, and n=1 for prolonged labour). In additional analyses, we checked and confirmed that inclusion of these studies did not substantially affect the estimates. We examined heterogeneity with the τ² statistic. For each meta-analytic model, we checked for evidence of small study bias by examination of funnel plots and Egger's test statistics.

We also explored the potential interaction of gestational weight gain with body mass index before pregnancy by assigning the category specific median values to each category of body mass index and gestational weight gain, and examined these as continuous predictors. This approach was taken to preserve the ordinal nature of the body mass index and gestational weight gain categories in the primary analysis while maintaining power, and has been used previously.33 Before undertaking these analyses, we used likelihood ratio tests to check and confirm the assumption of linearity of associations for body mass index and gestational weight gain. We pooled study specific estimates for parameters expressing the multiplicative interaction between these two predictors. Where pooled interaction estimates were significant, we grouped models by the body mass index category before pregnancy (underweight, normal, and overweight or obese, defined according to the thresholds mentioned above) to understand differences in associations.

Finally, we examined the robustness of associations by repeating the primary analyses with gestational weight gain adequacy defined according to the INTERGROWTH-21st standards. We also checked the robustness of the estimates by repeating the primary analyses only in women with measured (ie, non-imputed) weight before pregnancy or first trimester weight, and with complete case analysis to deal with missing data. Also, to examine the robustness of the primary approach used to deal with missing data, we used multiple imputation with chained equations to handle missing data for models examining caesarean delivery. Data were imputed for the outcome (caesarean delivery) and all relevant covariates. Imputation was undertaken separately for each study, and the imputation model included the outcome variable and all covariates. A total of 20 datasets were generated for each study, with information from all datasets pooled to obtain the final study specific estimate that was taken forward for the meta-analysis. We also repeated the meta-analyses only with studies considered to be at overall low risk of bias (defined as having a low risk of bias in all domains assessed, or with a moderate risk of bias in a maximum of one domain). All analyses were conducted with Stata 16 (StataCorp, TX).

Patient and public involvement

Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research, as it was a secondary analysis based on data from previous studies. Study results will not be sent to individual participants; however they may be disseminated to relevant patient and public communities.

Results

We included 61 studies with 156 300 participants with data on gestational weight gain, across 23 low and middle income countries (table 1 and online supplemental table 2). Overall, 34.4% (n=21) of studies were based in sub-Saharan Africa, 29.5% (n=18) in Latin America and the Caribbean, and 26.2% (n=16) in South Asia (table 1). Because of differences in sample sizes, the greatest proportion of participants were based in South Asia (n=78 454, 50.2%), followed by sub-Saharan Africa (n=36 327, 23.2%), and North Africa and the Middle East (n=23 867, 15.3%, from one study based in Iran). Five studies with sample sizes of ≥10 000 contributed 55.8% (n=87 272) of all participants.34–37

Table 1.

Characteristics of included studies (n=61) and participants (n=156 300) considered in analyses

Studies Participants
World region
 Latin America and the Caribbean 18 (29.5) 9900 (6.3)
 North Africa and the Middle East 1 (1.6) 23 867 (15.3)
 South Asia 16 (26.2) 78 454 (50.2)
 South East Asia, East Asia, and Oceania 5 (8.2) 7752 (5.0)
 Sub-Saharan Africa 21 (34.4) 36 327 (23.2)
Maternal age (years)
 <20 30 666 (19.6)
 20-24 54 526 (34.9)
 25-29 39 638 (25.4)
 ≥30 31 470 (20.1)
Maternal education (years)
 0-4 39 206 (25.1)
 5-7 23 154 (14.8)
 8-11 30 738 (19.7)
 ≥12 15 953 (10.2)
 Missing 47 249 (30.2)
Body mass index before pregnancy or in first trimester
 Underweight 25 338 (16.2)
 Normal 99 803 (63.9)
 Overweight 23 017 (14.7)
 Obese 8142 (5.2)
Gestational weight gain adequacy*
 Severely inadequate (<70%) 53 860 (34.5)
 Moderately inadequate (70% to <90%) 33 773 (21.6)
 Adequate (90% to 125%) 37 146 (23.8)
 Excessive (>125%) 31 521 (20.2)

Data are number (%).

*Defined as ratio of observed gestational weight gain versus gestational weight gain recommended in line with 2009 guidelines from the Institute of Medicine.

At baseline, 19.6% (n=30 666) of women were aged <20 years and 20.1% (n=31 470) were aged ≥30 years. Of women with data available (n=109 051), 57.2% (n=62 360) had completed 0-7 years of education. Most women had a normal body mass index before pregnancy or in the first trimester, with 16.2% (n=25 338) classified as having underweight and 19.9% (n=31 159) as having overweight or obesity. We found severely inadequate gestational weight gain in 34.5% (n=53 860) of all women, moderately inadequate gestational weight gain in 21.6% (n=33 773), and excessive gestational weight gain in 20.2% (n=31 521) (table 1). First trimester weight was imputed for 50 623 (32.4%) women. Online supplemental tables 2-4 describe more study specific characteristics. The overall risk of bias across the included studies was generally low. Three (4.9%) studies were classified as having a high risk of bias in one domain and six (9.8%) studies as having a moderate risk of bias in two domains. Twenty two (36.1%) of studies were considered to have a low risk of bias across all domains assessed (online supplemental table 5).

Data on maternal outcomes of interest were available across distinct subsets of studies. The largest number of studies and participants was available for caesarean delivery (56 studies, 102 929 participants) and other immediate perinatal outcomes, with fewer studies available for postpartum outcomes, such as depressive symptoms and waist circumference (table 2). Among participants with available data, the proportion of women having caesarean or emergency caesarean delivery was 23.8% and 8.6%, respectively, and 11.3% of participants had perineal tears. Postpartum haemorrhage was observed or reported for 20.3% of participants (with this relatively high value from one study based on self-report36), and prolonged labour for 15.5% of participants. Postpartum measures were typically taken within the first year after delivery. For all participants with data available on depressive symptoms, most were taken at one time point, a median of 84 (interquartile range (IQR) 50) days post partum, and 10.5% of participants were classified as being in the highest study specific group (group 5, scores categorised as five equal groups) of symptom scores at any time. Based on multiple observations across participants, average values for postpartum body mass index, waist circumference, and blood pressure were within normal ranges. Almost all women were breastfeeding across all time points (93.2%, measured a median of 89 (IQR 125) days post partum), with 42.0% exclusively breastfeeding measured at a median of 105 (IQR 140) days post partum (table 2).

Table 2.

Summary¶ of available data on perinatal and postpartum outcomes of interest (n=61 studies)

No (%) of studies No of participants with available data No of observations (where repeated measures) No (%) with outcome, or mean (SD) of outcome Time point of measure (days post partum) (median (IQR))
No (%) of perinatal outcomes
 Caesarean delivery† 56 (91.8) 102 929 24 481 (23.8)
 Emergency caesarean delivery‡ 16 (26.2) 24 475 2106 (8.6)
 Perineal tears 8 (13.1) 46 136 5197 (11.3)
 Postpartum haemorrhage 11 (18.0) 48 978 9927 (20.3)
 Prolonged labour 9 (14.8) 54 150 8413 (15.5)
No (%) of psychosocial measures
 Highest group for depressive symptom score§ 7 (11.5) 19 417 21 540 2264 (10.5) 84 (50)
Postpartum weight and related measures
 Mean (SD) postpartum weight retained (kg) 32 (52.5) 63 214 153 017 1.7 (7.4) 84 (141)
 Mean (SD) body mass index 32 (52.5) 63 214 153 017 21.9 (4.8) 84 (141)
 Mean (SD) waist circumference (cm) 3 (4.9) 825 1712 87.7 (11.3) 44.5 (68)
 Mean (SD) systolic blood pressure (mm Hg) 17 (27.9) 23 302 56 913 107.1 (14.5) 99 (222)
 Mean (SD) diastolic blood pressure (mm Hg) 17 (27.9) 23 281 56 845 69.2 (8.7) 99 (222)
No (%) currently breastfeeding
 Any breastfeeding 14 (23.0) 43 194 144 241 134 425 (93.2) 89 (125)
 Exclusively breastfeeding 10 (16.4) 29 915 128 854 54 129 (42.0) 105 (140)

*For repeated measures, summaries are based on all observations (non-unique participants).

†Caesarean delivery includes both emergency and scheduled caesarean delivery.

‡Denominator for emergency caesarean delivery includes all deliveries (vaginal delivery, and emergency and scheduled caesarean delivery).

§Depressive symptom scores were measured with the Edinburgh Postnatal Depression Scale (three studies and subset of one study), Patient Health Questionnaire 9 (one study), Centre for Epidemiologic Studies-depression scale (one study), Self-Report Questionnaire 20 (subset of one study), and a study specific tool (one study). Scores categorised as five equal groups (20% each of sample) within each study.

¶Summary measures are based on observations with available data on gestational weight gain adequacy.

IQR, interquartile range; SD, standard deviation.

Compared with women having adequate gestational weight gain, women with excessive gestational weight gain had a 10% increased risk of caesarean delivery (risk ratio 1.10, 95% confidence interval (CI) 1.06 to 1.13, τ2=0.000) (table 3 and online supplemental figures 1-3). In contrast, women with moderately and severely inadequate versus adequate gestational weight gain had lower risks of caesarean delivery (risk ratio for moderately inadequate gestational weight gain 0.88, 95% CI 0.84 to 0.92, τ2=0.004; risk ratio for severely inadequate gestational weight gain 0.82, 0.77 to 0.88, τ2=0.010). We observed similar trends for emergency caesarean delivery (compared with adequate gestational weight gain, risk ratio for excessive gestational weight gain 1.22, 95% CI 1.03 to 1.43, τ2=0.000; risk ratio for moderately inadequate gestational weight gain 0.82, 0.71 to 0.95, τ2=0.004; risk ratio for severely inadequate gestational weight gain 0.73, 0.56 to 0.96, τ2=0.103). We found no clear evidence for associations between gestational weight gain and the risk of perineal tears, postpartum haemorrhage, prolonged labour, or depressive symptoms in the postpartum period, although severely inadequate versus adequate gestational weight gain was associated with a modest decrease in the risk of postpartum haemorrhage (table 3 and online supplemental figures 4-18).

Table 3.

Associations between suboptimal gestational weight gain versus adequate gestational weight gain and maternal perinatal and postpartum outcomes

No of studies No of participants or observations* No of participants with event† Risk ratio or mean difference (95% CI) τ2
Severely inadequate gestational weight gain
Perinatal outcomes (risk ratio)
 Caesarean delivery‡ 55  53 135  10 270 0.82 (0.77 to 0.88) 0.010
 Emergency caesarean delivery 15  13 719  1026 0.73 (0.56 to 0.96) 0.103
 Perineal tears 8  29 962  3290 0.95 (0.88 to 1.02) 0.000
 Postpartum haemorrhage 11  31 389  7412 0.91 (0.86 to 0.96) 0.000
 Prolonged labour 9  37 867  5928 0.82 (0.63 to 1.06) 0.050
Psychosocial measures (risk ratio)
 Highest group for depressive symptom score§ 7  12 416  1343 0.99 (0.94 to 1.04) 0.000
Postpartum weight and related measures (mean difference)
 Postpartum weight retained (kg) 32  99 021   −2.82 (−3.47 to −2.17) 2.257
 Body mass index 32  99 021   −1.16 (−1.40 to −0.92) 0.326
 Waist circumference (cm) 3  870   −3.05 (−8.14 to 2.05) 1.744
 Systolic blood pressure (mm Hg) 17  30 449   −1.15 (−2.03 to −0.28) 1.515
 Diastolic blood pressure (mm Hg) 17  30 421   −0.58 (−0.96 to −0.20) 0.056
Currently breastfeeding (risk ratio)
 Any breastfeeding 14  97 586  91 046 1.00 (1.00 to 1.00) 0.000
 Exclusively breastfeeding 10  89 484  36 587 0.99 (0.95 to 1.03) 0.001
Moderately inadequate gestational weight gain
Perinatal outcomes (risk ratio)
 Caesarean delivery‡ 54  48 047  10 638 0.88 (0.84 to 0.92) 0.004
 Emergency caesarean delivery 15  12 249  978 0.82 (0.71 to 0.95) 0.004
 Perineal tears 8  21 069  2592 0.90 (0.78 to 1.03) 0.012
 Postpartum haemorrhage 10  22 081  3757 0.97 (0.91 to 1.04) 0.000
 Prolonged labour 9  23 219  3648 1.01 (0.94 to 1.09) 0.000
Psychosocial measures (risk ratio)
 Highest group for depressive symptom score§ 7  10 405  981 0.98 (0.93 to 1.03) 0.000
Postpartum weight and related measures (mean difference)
 Postpartum weight retained (kg) 32  69 595   −1.13 (−1.40 to −0.85) 0.391
 Body mass index 32  69 595   −0.81 (−1.00 to −0.62) 0.193
 Waist circumference (cm) 3  734   −1.98 (−5.89 to 1.92) 1.722
 Systolic blood pressure (mm Hg) 17  30 481   −0.80 (−1.43 to −0.16) 0.322
 Diastolic blood pressure (mm Hg) 17  30 453   −0.47 (−1.05 to 0.11) 0.182
Currently breastfeeding (risk ratio)
 Any breastfeeding 14  61 693  57 987 1.00 (1.00 to 1.00) 0.000
 Exclusively breastfeeding 10  53 252  24 074 0.99 (0.95 to 1.03) 0.000
Excessive gestational weight gain
Perinatal outcomes (risk ratio)
 Caesarean delivery‡ 50  55 379  17 539 1.10 (1.06 to 1.13) 0.000
 Emergency caesarean delivery 14  10 190  1202 1.22 (1.03 to 1.43) 0.000
 Perineal tears 8  16 069  2175 1.06 (0.93 to 1.21) 0.008
 Postpartum haemorrhage 11  17 438  1636 0.99 (0.50 to 1.97) 0.608
 Prolonged labour 9  13 092  1935 1.03 (0.86 to 1.22) 0.000
Psychosocial measures (risk ratio)
 Highest group for depressive symptom score§ 7  10 639  1040 1.04 (0.98 to 1.11) 0.000
Postpartum weight and related measures (mean difference)
 Postpartum weight retained (kg) 32  50 410   2.00 (1.49 to 2.50) 1.317
 Body mass index 32  50 410   0.96 (0.70 to 1.23) 0.299
 Waist circumference (cm) 3  948   0.85 (−0.56 to 2.26) 0.000
 Systolic blood pressure (mm Hg) 17  28 801   0.36 (−0.92 to 1.65) 1.740
 Diastolic blood pressure (mm Hg) 17  28 773   1.12 (−0.49 to 2.74) 7.368
Currently breastfeeding (risk ratio)
 Any breastfeeding 14  44 064  40 874 1.00 (1.00-1.00) 0.000
 Exclusively breastfeeding 10  34 792  16 512 0.99 (0.96 to 1.03) 0.000

Gestational weight gain adequacy was defined as the ratio of observed gestational weight gain versus gestational weight gain recommended in the 2009 guidelines from the Institute of Medicine. Severely inadequate gestational weight gain was defined as gestational weight gain adequacy ratio <70%, moderately inadequate as 70% to <90%, adequate as 90-125%, and excessive as >125%.

Estimates pooled with the random effects meta-analysis (restricted maximum likelihood (REML) method), with Hartung-Knapp adjustment for standard errors.

*Number of participants or number of observations for repeated measures (postpartum depressive symptoms, weight and related measures, and breastfeeding), for each comparison.

†Number of participants with event where risk ratio is reported.

‡Caesarean delivery includes both emergency and scheduled caesarean delivery.

§Scores categorised as five equal groups within each study.

CI, confidence interval.

For postpartum weight and related outcomes, women with moderately and severely inadequate gestational weight gain had lower weight retention at any postpartum time point than women having adequate gestational weight gain (mean difference for severely inadequate gestational weight gain −2.82 kg, 95% CI −3.47 to −2.17, τ2=2.257; mean difference for moderately inadequate gestational weight gain −1.13 kg, −1.40 to −0.85, τ2=0.391), whereas women with excessive gestational weight gain retained on average 2.00 kg more weight (95% CI 1.49 to 2.50, τ2=1.317) versus those with adequate gestational weight gain (table 3 and online supplemental figures 19-21). We observed similar differences for postpartum body mass index: compared with adequate gestational weight gain, excessive gestational weight gain was associated with higher postpartum body mass index (mean difference 0.96, 95% CI 0.70 to 1.23, τ2=0.299), whereas moderately and severely inadequate gestational weight gain were associated with progressively lower body mass index (mean difference for severely inadequate gestational weight gain −1.16, −1.40 to −0.92, τ2=0.326).

Relative to women with adequate gestational weight gain, those with moderately and severely inadequate gestational weight gain had a lower postpartum systolic blood pressure (mean difference for moderately inadequate gestational weight gain −0.80 mm Hg, 95% CI −1.43 to −0.16, τ2=0.322; mean difference for severely inadequate gestational weight gain −1.15 mm Hg, −2.03 to −0.28, τ2=1.515), with similar trends observed for postpartum diastolic blood pressure (table 3 and online supplemental figures 22-33). Gestational weight gain was not found to be associated with waist circumference, or with any breastfeeding or exclusively breastfeeding at any time point (table 3 and online supplemental figures 34-39). When examining associations with 95% prediction intervals, significance was achieved only for associations between severely inadequate versus adequate gestational weight gain and postpartum haemorrhage, and excessive versus adequate gestational weight gain and caesarean or emergency caesarean delivery (online supplemental table 6).

Pooled estimates for interaction indicated that the associations between gestational weight gain and risk of caesarean delivery, postpartum weight retention, postpartum body mass index, and postpartum systolic blood pressure were modified by body mass index category before pregnancy (online supplemental table 7). Severely inadequate versus adequate gestational weight gain was significantly associated with a reduced risk of caesarean delivery only among those with underweight or a normal body mass index before pregnancy. Moderately inadequate versus adequate gestational weight gain was associated with a reduced risk of caesarean delivery, and excessive versus adequate gestational weight gain was associated with an increased risk of caesarean delivery, only among those with a normal body mass index. Associations were not significant for women with overweight or obesity measured before pregnancy (figure 3 and online supplemental table 8). Associations between severely inadequate, moderately inadequate, and excessive gestational weight gain and postpartum weight retained were largely similar across all body mass index categories. Similar trends were observed when examining postpartum body mass index as the outcome (figure 3 and online supplemental table 8). Conversely, we found no clear evidence of differences in associations between gestational weight gain and systolic blood pressure across body mass index categories.

Figure 3.

Figure 3

Associations between suboptimal gestational weight gain and key maternal perinatal and postpartum outcomes, grouped by maternal body mass index before pregnancy. Gestational weight gain adequacy was defined as ratio of observed gestational weight gain versus gestational weight gain recommended in line with 2009 guidelines from the Institute of Medicine. Severely inadequate gestational weight gain was defined as gestational weight gain adequacy ratio <70%, moderately inadequate as 70% to <90%, adequate as 90-125%, and excessive as >125%

Estimates of association and trends observed remained substantially unchanged when using gestational weight gain adequacy expressed with INTERGROWTH-21st standards for women with a normal body mass index before pregnancy (online supplemental table 9), when analyses were restricted to participants with measured weight before pregnancy or in the first trimester (online supplemental tables 10 and 11) and when complete case analysis was used (online supplemental table 12), and when multiple imputation was used to deal with missingness in models examining caesarean delivery (online supplemental table 13 and supplemental figures 40-42). Generally, we found no clear evidence of small study bias, except for models examining the relation between severely inadequate gestational weight gain and systolic blood pressure, and for all models examining prolonged labour (online supplemental table 14). Estimates across all meta-analyses remained generally unchanged when our analysis was restricted to studies considered to be at low overall risk of bias (online supplemental table 15).

Discussion

Principal findings

Suboptimal gestational weight gain, including inadequate or excessive gestational weight gain, is an important predictor of maternal outcomes in the perinatal and postpartum periods, but evidence from low and middle income countries has been limited. In our set of individual participant data meta-analyses based on more than 150 000 women across 61 studies in 23 low and middle income countries, we found associations between suboptimal gestational weight gain and immediate perinatal and postpartum maternal outcomes. The risks of caesarean and emergency caesarean delivery were higher among women with excessive gestational weight gain versus those with adequate gestational weight gain, and lower among women with moderately and severely inadequate gestational weight gain. Women with excessive gestational weight gain were also more likely to retain more weight and have a higher body mass index post partum than those with adequate gestational weight gain. Moderately and severely inadequate gestational weight gain were associated with lower retained weight and postpartum body mass index.

We observed signs of lower postpartum systolic and diastolic blood pressure among women with moderately and severely inadequate gestational weight gain. Conversely, we did not observe clear associations between gestational weight gain and perineal tears, postpartum haemorrhage, prolonged labour, postpartum depressive symptoms, waist circumference, or breastfeeding status. The evidence indicated that the association between gestational weight gain adequacy and risk of caesarean delivery, postpartum weight retention, body mass index, and systolic blood pressure was modified by body mass index category before pregnancy. Hence these findings indicate potentially important associations between gestational weight gain and the risk of adverse maternal outcomes at delivery and in the longer term.

Comparison with other studies

Previous research has examined associations between suboptimal gestational weight gain and increased risk of immediate perinatal complications, although these studies were often based in high income or upper middle income countries and focused mainly on excessive gestational weight gain. These associations included increased risk of caesarean delivery,2 13 38 39 perineal tears,13 39 obstructed labour,5 and postpartum haemorrhage.38 39 Apart from caesarean delivery, the totality of evidence has remained somewhat less consistent about the association between excessive gestational weight gain and these outcomes.2 5 13 38 39 Fetal size is hypothesised as a potentially plausible mechanism for the observed associations, with excessive gestational weight gain leading to larger fetal size relative to maternal pelvic size (including by pathways such as gestational diabetes mellitus40), resulting in complications during labour and the potential need for an emergency caesarean delivery.13 Anticipated complications in labour potentially associated with excessive gestational weight gain may also result in scheduled caesarean deliveries, as has been noted for gestational diabetes mellitus.41 Additional mechanisms have also been proposed, including the potential role of increased pelvic soft tissues narrowing the birth canal.38

Excessive gestational weight gain has been linked to fetal macrosomia,1 in turn associated with uterine atony,42 a risk factor for postpartum haemorrhage.43 In line with this prior evidence, we observed an increased risk of caesarean delivery and emergency caesarean delivery among women with excessive gestational weight gain, which may be explained by the pathways described above. In stratified models, the increased risk of caesarean delivery with excessive gestational weight gain was mainly found in those who had a normal body mass index before pregnancy, suggesting an increased need to focus on this subgroup as potentially at higher risk. Reduced sample sizes in stratified models, however, limited definitive conclusions. Also, consistent with previous research,39 we also observed trends for a decreased risk of caesarean delivery with inadequate gestational weight gain. This finding might be explained by smaller fetal size relative to maternal pelvic size, which may reduce the risk of complications during labour and associated risk for emergency caesarean delivery, compared with having a fetus of normal size. We, however, reiterate the previously observed strong associations between moderately and severely inadequate gestational weight gain and a range of adverse neonatal outcomes, including low birth weight, small for gestational age, and microcephaly.1 These associations indicate the strong negative potential influences on several other pregnancy related outcomes, highlighting the greater overall costs to maternal and child health of insufficient weight gain during pregnancy. No conclusive evidence of associations between inadequate or excessive gestational weight gain and other immediate perinatal outcomes was found from these analyses.

Similarly, the relation between gestational weight gain and postpartum weight retention, body mass index, and waist circumference has more often been examined in higher income settings, with strong evidence indicating positive associations, including up to at least three years post partum.8–10 13 44 45 Our analysis provides further evidence from low and middle income countries supporting these data. Measures of adiposity, including weight and body mass index, are strongly associated with blood pressure, hypothesised to be caused by a range of biological mechanisms, including through influences on the sympathetic nervous system, renin-angiotensin-aldosterone and natriuretic peptides systems, and hyperinsulinaemia.46 47 Consistent with these hypotheses, we observed similar trends for postpartum systolic and diastolic blood pressure across categories of gestational weight gain adequacy as for postpartum weight retention and body mass index, although the positive associations between excessive gestational weight gain and postpartum blood pressure were not significant.

Associations between excessive gestational weight gain and higher postpartum anthropometric measures likely reflect maternal protein and fat mass accretion during pregnancy.20 Furthermore, excessive gestational weight gain in early pregnancy is linked to an increased risk of gestational diabetes mellitus,48 which in turn has been associated with increases in cardiometabolic risk in the postpartum period, including higher anthropometric measures, hypertension, dysglycaemia, and type 2 diabetes.49 50 Our analysis provides further evidence from low and middle income countries supporting this finding, and because we did not exclude women with gestational diabetes mellitus, may at least partly reflect these pathways. With evidence of links between overweight and obesity and risk of cardiovascular disease and diabetes, including in women in middle age and post partum,51 52 these results suggest an increased risk of potentially longer term negative maternal cardiometabolic health associated with excessive gestational weight gain, especially important in women with overweight or obesity before pregnancy who may already have a higher risk of adverse outcomes.

Considering the J shaped association between body mass index and blood pressure, and adverse long term outcomes, the clinical significance of a one unit increase in these measures (as approximately observed in our analysis) would depend on initial body mass index or blood pressure, and may be particularly important for women with overweight or obesity before pregnancy.53 54 Furthermore, with nutrition transitions and increasing average body mass index and blood pressure among women, including women of reproductive age,55 56 these results indicate potentially important implications in terms of cardiometabolic risk in later life. The potential importance of preventing excessive gestational weight gain among women with higher overweight or obesity before pregnancy is also supported by the slightly greater magnitude of positive associations between gestational weight gain and postpartum body mass index in this group versus women with a normal body mass index or with underweight. These differences were not substantial, however, suggesting that all women may have potential to benefit from interventions aimed at preventing excessive gestational weight gain.

The prevalence of underweight among women of reproductive age in low and middle income countries is substantial,57 58 and our findings suggested a potential need to more comprehensively explore long term suboptimal nutritional status in women with severely inadequate gestational weight gain, including features of maternal nutritional depletion, which may affect both future pregnancies and longer term maternal health.53 59 Furthermore, although inadequate gestational weight gain was associated with lower postpartum weight retained, body mass index, and blood pressure, previous evidence indicating potentially negative neonatal outcomes associated with inadequate gestational weight gain is important to consider to fully understand the risks associated with lower than optimal gestational weight gain.1–3

Excessive gestational weight gain could contribute to the development of depressive symptoms through pathways arising from increased adiposity in the postpartum period (eg, dysregulation of the hypothalamic-pituitary-adrenal axis, inflammatory mechanisms associated with adiposity, or other mechanisms related to body image), which may lead to adverse cognitive and affective changes.60 61 Previous evidence has also indicated an increased risk of postpartum depression in those with inadequate gestational weight gain, possibly because of underlying mechanisms related to hunger or food insecurity.7 60 62 Our analysis did not indicate associations between suboptimal gestational weight gain and postpartum depressive symptoms, possibly because of the smaller analytical sample sizes, heterogeneity of scales used, and setting specific validity of the scales used to measure depressive symptoms. Although we examined study specific scores, meta-analyses covered four distinct subjective scales, and a clumped distribution of scores in studies was observed in the highest group, comprising <20% of the observations. These factors may have contributed to imprecise estimates. Future large scale studies examining the relation between gestational weight gain and postpartum depressive symptoms based on consistent and validated scales are needed.

Previous evidence suggested that a high body mass index before pregnancy and gestational weight gain may have negative effects on breastfeeding. This finding may be a result of multiple pathways, including increased risk of perinatal complications which may prevent breastfeeding, metabolic effects,63 or difficulties with latching and lactation that are associated with adiposity.6 15 64 65 Although associations between inadequate gestational weight gain and starting breastfeeding have been reported,6 no clear evidence for underlying mechanisms was found. We found no evidence of associations between suboptimal gestational weight gain and breastfeeding in our analysis, suggesting no independent effect compared with other determinants.66 Methodological heterogeneity across studies, however, particularly for the specific questions asked to determine exclusive breastfeeding, may also at least partly explain the lack of associations observed.

We found an increased risk of caesarean delivery of about 10% and an increased risk of emergency caesarean delivery of about 20% associated with excessive gestational weight gain. The magnitude of the increase in risk, particularly for emergency caesarean delivery, may be considered clinically important, particularly because of the evidence indicating an increased likelihood of adverse short and long term outcomes associated with caesarean delivery.67 Although our analyses were observational and causality must first be confirmed, our findings indicate that preventing excessive gestational weight gain in low and middle income countries may be important in reducing the risk of caesarean delivery in these populations. This implication may be particularly relevant for women with a normal body mass index before pregnancy, among whom stratified models indicated some evidence of an increased risk. The evidence provided in these models, however, may not be enough to warrant differential recommendations for women in different categories of body mass index before pregnancy.55 The burden of excessive gestational weight gain is notable in low and middle income countries,18 19 alongside increasing body mass index,55 56 with multiple barriers to accessing quality, comprehensive emergency obstetric care in these settings—reiterating the potential importance of this finding.68 Dietary and physical activity approaches in pregnancy may be useful.69 These approaches must consider appropriate balancing of intervention intensity and monitoring of gestational weight gain to ensure that inadequate gestational weight gain is avoided, particularly considering the previously established associations between inadequate gestational weight gain and suboptimal neonatal outcomes.1–3

Experimental data based on low and middle income countries indicate a potentially important effect of strategies targeting diet and physical activity for excessive gestational weight gain on reducing the risk of caesarean delivery in women with overweight.69 Experimental evidence from low and middle income countries is scarce, however, and further research would be valuable in establishing causality and exploring potentially suitable preventive strategies.2 Although our results also indicate associations between excessive gestational weight gain and increases in common measures of cardiometabolic risk, longer term data on a more comprehensive set of risk factors are needed to better understand potential implications. These data could include measures related to the development of type 2 diabetes, because excessive gestational weight gain in early pregnancy has been associated with the risk of gestational diabetes mellitus,48 which is linked to later occurrence of type 2 diabetes.49 Regardless, strong evidence exists indicating that suboptimal gestational weight gain is associated with poor neonatal and other outcomes, including low birth weight,1–3 which are associated with poor long term health.70 Our analysis adds to this overall evidence supporting the need to attain optimal gestational weight gain for improved maternal and offspring health in low and middle income countries.

Strengths and limitations of this study

Our study had some limitations. Although our meta-analyses were based on a large pool of studies and participants, we could not include several studies initially identified as part of our systematic searches for multiple reasons, ranging from lack of response from contacted investigators to data sharing arrangements not being completed on time relative to the end of funding for the project. Because of the observational nature of the data, residual confounding is possible, including for analyses exploring longer term outcomes. Although we adjusted for socioeconomic measures, such as maternal education and wealth, residual confounding cannot be excluded entirely for some associations, particularly those observed between moderately and severely inadequate gestational weight gain and reduced risk of caesarean delivery. In analyses examining caesarean and emergency caesarean delivery, we also did not have data available to account for access to obstetric care. In general, because the analyses covered studies based in a range of settings from low and middle income countries in multiple geographic regions, heterogeneity may have existed across several factors that we could not investigate more closely because of data limitations, including differences in: access to obstetric care; sociocultural practices related to breastfeeding and exclusive breastfeeding; practices related to pregnancy and postpartum diet, and exercise and weight monitoring; and cultural perspectives on depression and interpretation of questions related to depressive symptoms. In particular, we did not have specific information on algorithms of care for different settings in relation to perinatal complications, especially caesarean delivery. This information would be valuable to more clearly distinguish clinical pathways explaining associations, such as decisions by healthcare providers for scheduled caesarean delivery or advice on weight management, versus biological mechanisms, such as fetal size leading to a potentially increased or reduced risk of complications at labour and subsequent emergency caesarean delivery. These factors may have important influences on gestational weight gain adequacy and the risk of later outcomes, thus potentially affecting associations, and should be examined closely in future studies.

Analyses were restricted to participants with information available to calculate the gestational weight gain metrics of interest. We did not undertake imputation for missing data, including for outcomes and covariates. In a limited sensitivity analysis examining caesarean delivery, we observed no substantial difference in estimates when dealing with missing data with multiple imputation with chained equations, suggesting that our approach of the use of the missing indicator and complete case analysis methods to deal with missing data was relatively robust. We cannot fully exclude potential bias, however, if data may be missing not at random for all outcomes, particularly with the missing indicator method or complete case analysis approaches.71 First trimester weight was imputed for a substantial proportion of women, and although we observed consistent results in sensitivity analyses restricted to women with measured weight before pregnancy or in the first trimester, we cannot completely exclude errors in weight imputation.

Follow-up was generally limited to the first one or two years post partum, with limited longer term data. Bias from selective attrition may not be entirely excluded, especially for longer term data. Furthermore, self-report of some measures of interest, particularly immediate perinatal variables, such as postpartum haemorrhage, may have reduced the accuracy of the measurement, with potential effects on the strength of associations observed. We also found heterogeneity in the scales used to define postpartum depressive symptoms, which may have affected the findings. Data for some immediate perinatal outcomes were less common than for specific outcomes, such as caesarean delivery or postpartum weight. Although generally we found no clear evidence for small study bias in these cases, Egger's test statistics were significant for prolonged labour, and the smaller sample size for these outcomes may have limited statistical power. This finding indicates the need for more systematic collection and reporting of these measures to understand immediate perinatal health in relation to gestational weight gain.

We examined gestational weight gain adequacy and body mass index as categorical variables to enable interpretation for clinical and public health impact. This approach is limited statistically, including loss of information, and hence future analyses should investigate these variables as continuous measures, and examining linearity of associations with maternal outcomes would be informative. We used two stage meta-analytical approaches to obtain pooled estimates, the assumptions of which may be unreliable when most studies have sparse outcome events.72 This approach may have affected estimates of a limited number of meta-analytic models examining immediate perinatal outcomes with fewer overall studies. We also could not more closely examine potential differences in associations for suboptimal gestational weight gain in early versus late pregnancy, or changing trajectories in gestational weight gain adequacy across pregnancy including in response to recommendations from clinical providers (eg, for gestational diabetes mellitus or scheduled caesarean delivery) because of reduced data availability.

We could not examine the relation between specific components of gestational weight gain (eg, gain in weight or body mass index of the mother v other components, such as the placenta) and the outcomes of interest. Investigating this relation would more clearly separate the underlying pathways so we can understand to what extent weight at delivery (or specific components of weight gain) may explain the associations observed. These analyses would require more complex statistical considerations to more formally investigate and quantify mediation by these characteristics. Because our primary question was establishing associations of gestational weight gain with these outcomes, and because weight at delivery was not always available in the studies included, we could not examine this question comprehensively in our analysis. Furthermore, detailed data from low and middle income countries, including weight at delivery, and quantifying specific components of weight gain (eg, measuring placental weight) would be valuable to explain these aspects. Discussions have taken place on the need to better define optimal and suboptimal gestational weight gain in low and middle income countries, including the need for references more representative of low and middle income countries.73 More comprehensive data would provide a clearer exploration of appropriate references and cut-off values to define suboptimal gestational weight gain in low and middle income countries.

Our analysis had several strengths. Analyses were based on a pool of large scale individual participant data from 23 low and middle income countries across five global regions, with relevant variables harmonized across all studies, and substantial sample sizes for most outcomes. Where associations were observed, the consistency in trends of associations across gestational weight gain categories suggested that these were not because of chance alone. Furthermore, our results are in line with previous literature, mainly from higher income countries examining the influence of suboptimal gestational weight gain on perinatal and postpartum maternal outcomes.4–10 13 14

Conclusions

Our findings support associations between gestational weight gain and the development of adverse maternal outcomes in the immediate perinatal and postpartum periods. Further research examining the later consequences of suboptimal gestational weight gain in low and middle income countries would be beneficial to inform the potential value and design of strategies to improve maternal health in the long term.

Acknowledgments

We are grateful to Sun-Eun Lee and Jian Yan (Bill and Melinda Gates Foundation, USA), and to the Gestational Weight Gain Pooling Project Phase 2 Technical Advisory Group members: Kathryn G Dewey (University of California, Davis, CA, USA), Karim Manji (Muhimbili University of Health and Allied Sciences, Tanzania), Linda Adair (University of North Carolina Gillings School of Global Public Health, NC, USA), and Anura Kurpad (St John's Research Institute, India) for their support of this work.

Footnotes

Contributors: WWF, EL, DW, MW, UP, JCC, and IRC contributed to conceptualisation of the study and investigation. BB, VS, and SKN, and all other authors of the Gestational Weight Gain Pooling Project Consortium, contributed to data acquisition and curation. All authors contributed to study methodology, and writing, review and editing. UP contributed to the formal analysis and wrote the original draft of the manuscript. WWF and UP contributed to project administration. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted. WWF is the guarantor. Transparency: The lead author (the guarantor) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.

Funding: This project was funded by the Bill and Melinda Gates Foundation (INV-000620 and INV-016436). The funder had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from the Bill and Melinda Gates Foundation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Provenance and peer review: Not commissioned; externally peer reviewed.

Supplemental material: This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

Contributor Information

Collaborators: Gestational Weight Gain Pooling Project Consortium

Data availability statement

Data may be obtained from a third party and are not publicly available. The datasets analysed during the study are not publicly available because the study was an analysis of data pooled from multiple individual studies. Data from individual studies may be available to share upon reasonable request to the individual study investigators.

Ethics approval

Ethics approval at the Harvard TH Chan School of Public Health was determined as not required because only de-identified data were shared for secondary analyses.

References

  • 1.Perumal N, Wang D, Darling AM, et al. Suboptimal gestational weight gain and neonatal outcomes in low and middle income countries: individual participant data meta-analysis. BMJ 2023;382:e072249. 10.1136/bmj-2022-072249 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Voerman E, Santos S, Inskip H, et al. Association of gestational weight gain with adverse maternal and infant outcomes. JAMA 2019;321:1702. 10.1001/jama.2019.3820 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chowdhury R, ▪ N, Choudhary TS, et al. Gestational weight gain and pregnancy outcomes: Findings from North Indian pregnancy cohort. Matern Child Nutr 2022;18:e13238. 10.1111/mcn.13238 [DOI] [Google Scholar]
  • 4.Goldstein RF, Abell SK, Ranasinha S, et al. Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis. JAMA 2017;317:2207–25. 10.1001/jama.2017.3635 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Morisaki N, Nagata C, Jwa SC, et al. Pre-pregnancy BMI-specific optimal gestational weight gain for women in Japan. J Epidemiol 2017;27:492–8. 10.1016/j.je.2016.09.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Huang Y, Ouyang Y-Q, Redding SR. Maternal prepregnancy body mass index, gestational weight gain, and cessation of breastfeeding: a systematic review and meta-analysis. Breastfeed Med 2019;14:366–74. 10.1089/bfm.2018.0138 [DOI] [PubMed] [Google Scholar]
  • 7.Zanardo V, Giliberti L, Giliberti E, et al. The role of gestational weight gain disorders in symptoms of maternal postpartum depression. Int J Gynaecol Obstet 2021;153:234–8. 10.1002/ijgo.13445 [DOI] [PubMed] [Google Scholar]
  • 8.Soria-Contreras DC, Rifas-Shiman SL, Aris IM, et al. Weight trajectories after delivery are associated with adiposity and cardiometabolic markers at 3 years postpartum among women in Project Viva. J Nutr 2020;150:1889–98. 10.1093/jn/nxaa104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Fraser A, Tilling K, Macdonald-Wallis C, et al. Associations of gestational weight gain with maternal body mass index, waist circumference, and blood pressure measured 16 y after pregnancy: the Avon Longitudinal Study of Parents and Children (ALSPAC). Am J Clin Nutr 2011;93:1285–92. 10.3945/ajcn.110.008326 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.McClure CK, Catov JM, Ness R, et al. Associations between gestational weight gain and BMI, abdominal adiposity, and traditional measures of cardiometabolic risk in mothers 8 y postpartum. Am J Clin Nutr 2013;98:1218–25. 10.3945/ajcn.112.055772 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Yu J, Pudwell J, Dayan N, et al. Postpartum breastfeeding and cardiovascular risk assessment in women following pregnancy complications. J Womens Health (Larchmt) 2020;29:627–35. 10.1089/jwh.2019.7894 [DOI] [PubMed] [Google Scholar]
  • 12.Blom EA, Jansen PW, Verhulst FC, et al. Perinatal complications increase the risk of postpartum depression. The Generation R Study. BJOG 2010;117:1390–8. 10.1111/j.1471-0528.2010.02660.x [DOI] [PubMed] [Google Scholar]
  • 13.Champion ML, Harper LM. Gestational weight gain: update on outcomes and interventions. Curr Diab Rep 2020;20:11. 10.1007/s11892-020-1296-1 [DOI] [PubMed] [Google Scholar]
  • 14.Tong M, Jin L, Liu J, et al. Association between gestational weight gain and exclusive breast-feeding for the first 6 months postpartum in Chinese women. Public Health Nutr 2019;22:2092–8. 10.1017/S1368980019000387 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nomura K, Kido M, Tanabe A, et al. Prepregnancy obesity as a risk factor for exclusive breastfeeding initiation in Japanese women. Nutrition 2019;62:93–9. 10.1016/j.nut.2018.11.003 [DOI] [PubMed] [Google Scholar]
  • 16.MacSween K, Whelan E, Woolcott CG. Gestational weight gain and perinatal outcomes in adolescent mothers: a retrospective cohort study. J Obstet Gynaecol Can 2016;38:338–45. 10.1016/j.jogc.2016.01.007 [DOI] [PubMed] [Google Scholar]
  • 17.Kirkegaard H, Stovring H, Rasmussen KM, et al. How do pregnancy-related weight changes and breastfeeding relate to maternal weight and BMI-adjusted waist circumference 7 y after delivery? Results from a path analysis. Am J Clin Nutr 2014;99:312–9. 10.3945/ajcn.113.067405 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Wang D, Wang M, Darling AM, et al. Gestational weight gain in low-income and middle-income countries: a modelling analysis using nationally representative data. BMJ Glob Health 2020;5:e003423. 10.1136/bmjgh-2020-003423 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Darling AM, Wang D, Perumal N, et al. Risk factors for inadequate and excessive gestational weight gain in 25 low- and middle-income countries: An individual-level participant meta-analysis. PLoS Med 2023;20:e1004236. 10.1371/journal.pmed.1004236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines . Weight gain during pregnancy: reexamining the guidelines. Washington (DC): National Academies Press (US), 2009. [Google Scholar]
  • 21.Liu E, Wang D, Darling AM, et al. Effects of prenatal nutritional supplements on gestational weight gain in low- and middle-income countries: a meta-analysis of individual participant data. Am J Clin Nutr 2022;116:1864–76. 10.1093/ajcn/nqac259 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Costa JC, Wang D, Wang M, et al. Gestational weight gain at the national, regional, and income group levels based on 234 national household surveys from 70 low-income and middle-income countries. PLOS Glob Public Health 2024;4:e0003484. 10.1371/journal.pgph.0003484 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Wang D, Partap U, Liu E, et al. The effect of prenatal balanced energy and protein supplementation on gestational weight gain: an individual participant data meta-analysis in low- and middle-income countries. PLoS Med 2025;22:e1004523. 10.1371/journal.pmed.1004523 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Liu E, Partap U, Shinde S, et al. Effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on maternal gestational weight gain in low-income and middle-income countries: a systematic review and individual participant data meta-analysis of randomised clinical trials. EClinicalMedicine 2025;84:103279. 10.1016/j.eclinm.2025.103279 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Yang J, Wang D, Darling AM, et al. Methodological approaches to imputing early-pregnancy weight based on weight measures collected during pregnancy. BMC Med Res Methodol 2021;21:24. 10.1186/s12874-021-01210-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Adu-Afarwuah S, Lartey A, Okronipa H, et al. Maternal supplementation with small-quantity lipid-based nutrient supplements compared with multiple micronutrients, but not with iron and folic acid, reduces the prevalence of low gestational weight gain in semi-urban Ghana: a randomised controlled trial. J Nutr 2017;147:697–705. 10.3945/jn.116.242909 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Obesity and overweight. 2015. Available: https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight
  • 28.de Onis M, Onyango AW, Borghi E, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007;85:660–7. 10.2471/blt.07.043497 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Cheikh Ismail L, Bishop DC, Pang R, et al. Gestational weight gain standards based on women enrolled in the Fetal Growth Longitudinal Study of the INTERGROWTH-21 st Project: a prospective longitudinal cohort study. BMJ 2016;352:i555. 10.1136/bmj.i555 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hayden JA, Côté P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006;144:427–37. 10.7326/0003-4819-144-6-200603210-00010 [DOI] [PubMed] [Google Scholar]
  • 31.Xu G, Song M, Zhou X, et al. The missing covariate indicator method is nearly valid almost always. arXiv [Preprint] 2021. 10.48550/arXiv.2111.00138 [DOI]
  • 32.Riley RD, Debray TPA, Fisher D, et al. Individual participant data meta‐analysis to examine interactions between treatment effect and participant‐level covariates: Statistical recommendations for conduct and planning. Stat Med 2020;39:2115–37. 10.1002/sim.8516 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wang S, Hu Y, Liu B, et al. Lignan intake and type 2 diabetes incidence among US men and women. JAMA Netw Open 2024;7:e2426367. 10.1001/jamanetworkopen.2024.26367 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Dwarkanath P, Muhihi A, Sudfeld CR, et al. Non-inferiority of low-dose compared to standard high-dose calcium supplementation in pregnancy: study protocol for two randomized, parallel group, non-inferiority trials in India and Tanzania. Trials 2021;22:838. 10.1186/s13063-021-05811-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Katz J, Khatry SK, Shrestha L, et al. Impact of topical applications of sunflower seed oil on neonatal mortality and morbidity in southern Nepal: a community-based, cluster-randomised trial. BMJ Glob Health 2024;9:e013691. 10.1136/bmjgh-2023-013691 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.West KP, Shamim AA, Mehra S, et al. Effect of maternal multiple micronutrient vs iron–folic acid supplementation on infant mortality and adverse birth outcomes in rural Bangladesh. JAMA 2014;312:2649. 10.1001/jama.2014.16819 [DOI] [PubMed] [Google Scholar]
  • 37.Ramezani Tehrani F, Behboudi-Gandevani S, Abedini M, et al. Cost effectiveness of different screening strategies for gestational diabetes mellitus screening: study protocol of a randomized community non-inferiority trial. Diabetol Metab Syndr 2019;11:106. 10.1186/s13098-019-0493-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Seligman LC, Duncan BB, Branchtein L, et al. Obesity and gestational weight gain: cesarean delivery and labor complications. Rev Saúde Pública 2006;40:457–65. 10.1590/S0034-89102006000300014 [DOI] [PubMed] [Google Scholar]
  • 39.Hung T-H, Chen S-F, Hsu J-J, et al. Gestational weight gain and risks for adverse perinatal outcomes: a retrospective cohort study based on the 2009 Institute of Medicine guidelines. Taiwan J Obstet Gynecol 2015;54:421–5. 10.1016/j.tjog.2015.06.010 [DOI] [PubMed] [Google Scholar]
  • 40.Gorgal R, Gonçalves E, Barros M, et al. Gestational diabetes mellitus: a risk factor for non-elective cesarean section. J Obstet Gynaecol Res 2012;38:154–9. 10.1111/j.1447-0756.2011.01659.x [DOI] [PubMed] [Google Scholar]
  • 41.Naylor CD, Sermer M, Chen E, et al. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? Toronto Trihospital Gestational Diabetes Investigators. JAMA 1996;275:1165–70. 10.1001/jama.1996.03530390031030 [DOI] [PubMed] [Google Scholar]
  • 42.Ignacio EA, Osman M, Igboagi U, et al. Management of the high-risk obstetric patient. In: Mauro MA, Murphy KP, Thomson KR, eds. Image-guided interventions. Boston: Elsevier, 2020. [Google Scholar]
  • 43.Dahlke JD, Bhalwal A, Chauhan SP. Obstetric emergencies. Obstet Gynecol Clin North Am 2017;44:231–43. 10.1016/j.ogc.2017.02.003 [DOI] [PubMed] [Google Scholar]
  • 44.Waits A, Guo C-Y, Chien L-Y. Comparison between American Institute of Medicine guidelines and local recommendation for gestational weight gain in Taiwanese primiparous women. Matern Child Health J 2021;25:1981–91. 10.1007/s10995-021-03231-2 [DOI] [PubMed] [Google Scholar]
  • 45.Fadzil F, Shamsuddin K, Wan Puteh SE, et al. Predictors of postpartum weight retention among urban Malaysian mothers: a prospective cohort study. Obes Res Clin Pract 2018;12:493–9. 10.1016/j.orcp.2018.06.003 [DOI] [PubMed] [Google Scholar]
  • 46.Linderman GC, Lu J, Lu Y, et al. Association of body mass index with blood pressure among 1.7 million Chinese adults. JAMA Netw Open 2018;1:e181271. 10.1001/jamanetworkopen.2018.1271 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduction on blood pressure. Hypertension 2003;42:878–84. 10.1161/01.HYP.0000094221.86888.AE [DOI] [PubMed] [Google Scholar]
  • 48.Carreno CA, Clifton RG, Hauth JC, et al. Excessive early gestational weight gain and risk of gestational diabetes mellitus in nulliparous women. Obstet Gynecol 2012;119:1227–33. 10.1097/AOG.0b013e318256cf1a [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Diaz-Santana MV, O’Brien KM, Park Y-MM, et al. Persistence of risk for type 2 diabetes after gestational diabetes mellitus. Diabetes Care 2022;45:864–70. 10.2337/dc21-1430 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Vilmi-Kerälä T, Palomäki O, Vainio M, et al. The risk of metabolic syndrome after gestational diabetes mellitus – a hospital-based cohort study. Diabetol Metab Syndr 2015;7:43. 10.1186/s13098-015-0038-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol 2018;3:280. 10.1001/jamacardio.2018.0022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Fan Y, Li W, Liu H, et al. Effects of obesity and a history of gestational diabetes on the risk of postpartum diabetes and hyperglycemia in Chinese women: Obesity, GDM and diabetes risk. Diabetes Res Clin Pract 2019;156:107828. 10.1016/j.diabres.2019.107828 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Bhaskaran K, dos-Santos-Silva I, Leon DA, et al. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol 2018;6:944–53. 10.1016/S2213-8587(18)30288-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Flint E, Webb E, Cummins S. Change in commute mode and body-mass index: prospective, longitudinal evidence from UK Biobank. Lancet Public Health 2016;1:e46–55. 10.1016/S2468-2667(16)30006-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Abarca-Gómez L, Abdeen ZA, Hamid ZA, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet 2017;390:2627–42. 10.1016/S0140-6736(17)32129-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Zhou B, Bentham J, Di Cesare M, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet 2017;389:37–55. 10.1016/S0140-6736(16)31919-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Development Initiatives . 2020 Global Nutrition Report: Action on Equity to End Malnutrition. Bristol, UK, 2020. Available: https://globalnutritionreport.org/reports/2020-global-nutrition-report/ [Google Scholar]
  • 58.Stevens GA, Beal T, Mbuya MNN, et al. Micronutrient deficiencies among preschool-aged children and women of reproductive age worldwide: a pooled analysis of individual-level data from population-representative surveys. Lancet Glob Health 2022;10:e1590–9. 10.1016/S2214-109X(22)00367-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.King JC. The risk of maternal nutritional depletion and poor outcomes increases in early or closely spaced pregnancies. J Nutr 2003;133:1732S–1736S. 10.1093/jn/133.5.1732S [DOI] [PubMed] [Google Scholar]
  • 60.Yamaguchi A, Kyozuka H, Kanno A, et al. Gestational weight gain and risk factors for postpartum depression symptoms from the Japan Environment and Children’s Study: a prospective cohort study. J Affect Disord 2021;283:223–8. 10.1016/j.jad.2021.01.080 [DOI] [PubMed] [Google Scholar]
  • 61.Hibbeln JR. Seafood consumption, the DHA content of mothers’ milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 2002;69:15–29. 10.1016/s0165-0327(01)00374-3 [DOI] [PubMed] [Google Scholar]
  • 62.Johar H, Hoffmann J, Günther J, et al. Evaluation of antenatal risk factors for postpartum depression: a secondary cohort analysis of the cluster-randomised GeliS trial. BMC Med 2020;18:227. 10.1186/s12916-020-01679-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Nommsen-Rivers LA. Does insulin explain the relation between maternal obesity and poor lactation outcomes? An overview of the literature. Adv Nutr 2016;7:407–14. 10.3945/an.115.011007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Huang L, Chen X, Zhang Y, et al. Gestational weight gain is associated with delayed onset of lactogenesis in the TMCHC study: A prospective cohort study. Clin Nutr 2019;38:2436–41. 10.1016/j.clnu.2018.11.001 [DOI] [PubMed] [Google Scholar]
  • 65.Walker RE, Harvatine KJ, Ross AC, et al. Fatty acid transfer from blood to milk is disrupted in mothers with low milk production, obesity, and inflammation. J Nutr 2023;152:2716–26. 10.1093/jn/nxac220 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Shi H, Yang Y, Yin X, et al. Determinants of exclusive breastfeeding for the first six months in China: a cross-sectional study. Int Breastfeed J 2021;16:40. 10.1186/s13006-021-00388-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Caughey AB, Cahill AG, Guise J-M, et al. Safe prevention of the primary cesarean delivery. Am J Obstet Gynecol 2014;210:179–93. 10.1016/j.ajog.2014.01.026 [DOI] [PubMed] [Google Scholar]
  • 68.Harrison MS, Goldenberg RL. Cesarean section in sub-Saharan Africa. Matern Health Neonatol Perinatol 2016;2:6. 10.1186/s40748-016-0033-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Feng Y, Shi C, Zhang C, et al. Effect of the smartphone application on caesarean section in women with overweight and obesity: a randomized controlled trial in China. BMC Pregnancy Childbirth 2023;23:746. 10.1186/s12884-023-06004-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Mericq V, Martinez-Aguayo A, Uauy R, et al. Long-term metabolic risk among children born premature or small for gestational age. Nat Rev Endocrinol 2017;13:50–62. 10.1038/nrendo.2016.127 [DOI] [PubMed] [Google Scholar]
  • 71.Hughes RA, Heron J, Sterne JAC, et al. Accounting for missing data in statistical analyses: multiple imputation is not always the answer. Int J Epidemiol 2019;48:1294–304. 10.1093/ije/dyz032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Riley RD, Ensor J, Hattle M, et al. Two-stage or not two-stage? That is the question for IPD meta-analysis projects. Res Synth Methods 2023;14:903–10. 10.1002/jrsm.1661 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.World Health Organization . Development of global gestational weight gain standards. Available: https://www.who.int/teams/nutrition-and-food-safety/development-of-global-gestational-weight-gain-standards [Accessed 8 Aug 2024].

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data

bmjmed-5-1-s001.pdf (9.6MB, pdf)

Data Availability Statement

Data may be obtained from a third party and are not publicly available. The datasets analysed during the study are not publicly available because the study was an analysis of data pooled from multiple individual studies. Data from individual studies may be available to share upon reasonable request to the individual study investigators.


Articles from BMJ Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES